# Anticoagulation in Stent Intervention

Study · id `cardio:ct-nct01141153` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01141153](<https://clinicaltrials.gov/study/NCT01141153>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01141153

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 304 participants.

## Technical summary

Registry record NCT01141153. Randomized; single masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 304 participants (planned count; ClinicalTrials.gov record NCT01141153, source copy `cardio:ctgov-nct01141153-2015-02-24`, retrieved 2026-10-26)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT01141153, source copy `cardio:ctgov-nct01141153-2015-02-24`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01141153, source copy `cardio:ctgov-nct01141153-2015-02-24`, retrieved 2026-10-26)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01141153, source copy `cardio:ctgov-nct01141153-2015-02-24`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT01141153, source copy `cardio:ctgov-nct01141153-2015-02-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01141153-2015-02-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Anticoagulation in Stent Intervention
- Acronym: MUSICA-2
- Condition: Atrial Fibrillation
- Condition: Stroke
- Intervention (Drug): Acetylsalicylic Acid + clopidogrel + acenocoumarol
- Intervention (Drug): Acetylsalicylic Acid + clopidogrel
- Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Hospital Universitari Vall d'Hebron Research Institute (`cardio:org-hospital-universitari-vall-d-hebron-research-institute`)

## Provenance

Content hash: ee4a040d75d97335231bf6f6dc5608d19473b47368d3d5386801ddc1ebede44b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
